ASTX727 (oral decitabine/cedazuridine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ASTX727 (oral decitabine/cedazuridine), covering 2025-11-10 to 2025-11-10. Get the full timeline:
Most recent: Clinical Trial Update: Testing Oral Decitabine and Cedazuridine (ASTX727) in Combination With Venetoclax for Higher-Risk Acute Myeloid Leukemia Patients [Phase 1, Phase 2]